Indianapolis
Indianapolis
Syngene’s India Biologics Facility Ready by Mid-Year
BIOT
📢 Syngene International's new biologics manufacturing facility in India to be operational from mid-year. 💉🏭 Tripled capacity, expansion plans underway!
Novartis Invests $100M to Revolutionize Cancer Therapy
BIOT
📢 Novartis is investing $100 million in expanding radioligand production in Indianapolis, supporting targeted therapies for prostate cancer. 🏥 🎯 This investment will create 100 new jobs, as Novartis aims to become a leader in radioligand therapy production. 💼
